רבלימיד 10 מג
neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 10 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
רבלימיד 15 מג
neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 15 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
רבלימיד 15 מג
neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 15 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
רבלימיד 25 מג
neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 25 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
רבלימיד 25 מג
neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 25 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
אוריזון וטרינרי
eliezer linevitz ltd. - clotrimazole; dexamethasone acetate; marbofloxacin - טיפות אוזניים - marbofloxacin 3 mg/ml; clotrimazole 10 mg/ml; dexamethasone acetate 0.9 mg/ml
דקסאמיצין טיפות עיניים
teva pharmaceutical indust.ltd - dexamethasone as sodium phosphate 1 mg/ml; neomycin as sulfate 5 mg/ml - ophthalmic solution - neomycin - steroid-responsive allergic and inflammatory disorders of the anterior segments of the eye (conjunctival, corneal, or uveal tract inflammation) or mechanical, chemical or thermal trauma where bacterial infection or a risk of bacterial ocular infection exists.
נינלארו 2.3 מג
takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 2.3 mg - ixazomib
נינלארו 2.3 מג
takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 2.3 mg - ixazomib
נינלארו 3 מג
takeda israel ltd - ixazomib as citrate - קפסולות - ixazomib as citrate 3 mg - ixazomib